Article

PCSK9 Eligibility Concerns Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Brain disease dementia problems with loss of memory function for alzheimers as a medical health care icon of neurology and mental illness as a pencil erasing neuron cells from the human anatomy. | Image Credit: Best_Seller | stock.adobe.com
September 17th 2025

Advances in Alzheimer Disease Treatment: A Transformative Time for Pharmacists

Anjeza Fero, PharmD, RPh
ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials
September 17th 2025

ESC 2023 Highlights: Insights on ALONE-AF and AQUATIC Trials

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
US FDA homepage, biosimilars -- Image credit: IB Photography | stock.adobe.com
September 17th 2025

FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab

Gillian McGovern, Associate Editor
Pharmacy focus oncology Edition, radon and lung cancer
September 17th 2025

A Silent Killer: Unmasking Radon’s Link to Lung Cancer

Alexandra Gerlach, Associate Editor
Miniature traveler looking for vaccine | Image Credit: © Yuan - stock.adobe.com
September 17th 2025

Rising Infectious Disease Threats Highlight Importance of Travel Vaccines

Alexandra Gerlach, Associate Editor
Vintage 1951 Vial of PENICILLIN G Produced by CSC Pharmaceuticals division of Commercial Solvents Corporation, New York, USA | Image Credit: Walter Cichetti | stock.adobe.com
September 17th 2025

Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation

Caitlyn Jerkins, PharmD Tracey Bastian, PharmD Rebecca Stern, MD Tyler Baumeister, PharmD, BCIDP
© 2025 MJH Life Sciences

All rights reserved.